Pregnancy-associated plasma protein-A (PAPP-A) and the proform of the eosinophil major basic protein (ProMBP) are associated with increased risk of death in heart failure patients.

about

Pregnancy-associated plasma protein-A (PAPP-A) and the proform of the eosinophil major basic protein (ProMBP) are associated with increased risk of death in heart failure patients.

Item

http://www.wikidata.org/entity/Q46525069

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pregnancy-associated plasma pr ...... ath in heart failure patients.

@en

type

Item

label

Pregnancy-associated plasma pr ...... ath in heart failure patients.

@en

prefLabel

Pregnancy-associated plasma pr ...... ath in heart failure patients.

@en

P1476

Pregnancy-associated plasma pr ...... ath in heart failure patients.

@en

P2093

Maja Dembic

http://www.w3.org/2001/XMLSchema#string

Michael Christiansen

http://www.w3.org/2001/XMLSchema#string

P2860

The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A

Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor

Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris

Biomarkers in heart failure

Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A

IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms

The insulin-like growth factor axis: A review of atherosclerosis and restenosis.

The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease.

Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study.

PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.

P304

352-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00365513.2017.1325926

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christian Torp-Pedersen

Lars Køber

Paula Louise Hedley

P577

2017-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28537443

http://www.w3.org/2001/XMLSchema#string